Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E H Jensen

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
European Journal of Neurology|February 28, 2014
Myasthenia and risk of cancer: a population-based case-control studyE G Pedersen, A Pottegård, J Hallas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 26, 2008
Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosisM Ravnborg, K Bendtzen, O Christensen, et al.
The British Journal of Surgery|March 18, 2010
Surgery alone is adequate treatment for early stage soft tissue sarcoma of the extremityW B Al-Refaie, E B Habermann, E H Jensen, et al.
Multiple Sclerosis and Related Disorders|July 6, 2019
Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008‒2018: A nationwide, population-based cohort studyMagnus S Boesen, Poul E H Jensen, Alfred P Born, et al.
European Journal of Neurology|June 30, 2009
Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluationF Sellebjerg, M Krakauer, D Hesse, et al.
Multiple Sclerosis and Related Disorders|July 7, 2023
NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosisC Ammitzbøll, T B Dyrby, L Börnsen, et al.
Journal of Public Health (Oxford, England)|November 2, 2022
The association of new-onset diabetes with subsequent diagnosis of pancreatic cancer-novel use of a large administrative databaseM J White, A C Sheka, C J LaRocca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2019
Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trialR S Herbst, P Baas, J L Perez-Gracia, et al.
Clinical and Experimental Immunology|May 12, 2015
Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortiumB Rup, M Pallardy, D Sikkema, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
European Journal of Neurology|February 28, 2014
Myasthenia and risk of cancer: a population-based case-control studyE G Pedersen, A Pottegård, J Hallas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 26, 2008
Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosisM Ravnborg, K Bendtzen, O Christensen, et al.
The British Journal of Surgery|March 18, 2010
Surgery alone is adequate treatment for early stage soft tissue sarcoma of the extremityW B Al-Refaie, E B Habermann, E H Jensen, et al.
Multiple Sclerosis and Related Disorders|July 6, 2019
Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008‒2018: A nationwide, population-based cohort studyMagnus S Boesen, Poul E H Jensen, Alfred P Born, et al.
European Journal of Neurology|June 30, 2009
Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluationF Sellebjerg, M Krakauer, D Hesse, et al.
Multiple Sclerosis and Related Disorders|July 7, 2023
NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosisC Ammitzbøll, T B Dyrby, L Börnsen, et al.
Journal of Public Health (Oxford, England)|November 2, 2022
The association of new-onset diabetes with subsequent diagnosis of pancreatic cancer-novel use of a large administrative databaseM J White, A C Sheka, C J LaRocca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2019
Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trialR S Herbst, P Baas, J L Perez-Gracia, et al.
Clinical and Experimental Immunology|May 12, 2015
Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortiumB Rup, M Pallardy, D Sikkema, et al.
Pageof 2